Drug · DIN 02488361
TIBELLA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 29, 2020; first marketed July 29, 2020.
- Drug Identification Number (DIN)
- 02488361
- Company (DIN owner)
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Schedule
- Controlled drugs (CDSA IV)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tibolone G03CX01
- Class
- Human
- Record last updated
- July 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TIBOLONE | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 10, 2019: NOC 22141New Drug Submission (NDS)